Home LiteratureArticle Details
PMID: 23086229 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Interruption of the ionic lock in the bradykinin B2 receptor results in constitutive internalization and turns several antagonists into strong agonists.

The Journal of pharmacology and experimental therapeutics ·Vol. 344 ·No. 1 ·2013-01-00 ·Pages 85-95

Leschner J, Wennerberg G, Feierler J, Bermudez M, Welte B, Kalatskaya I, Wolber G, Faussner A

Abstract

The DRY motif with the highly conserved R3.50 is a hallmark of family A G protein-coupled receptors (GPCRs). The crystal structure of rhodopsin revealed a salt bridge between R135(3.50) and another conserved residue, E247(6.30), in helix 6. This ionic lock was shown to maintain rhodopsin in its inactive state. Thus far, little information is available on how interruption of this ionic bond affects signaling properties of nonrhodopsin GPCRs, because the focus has been on mutations of R3.50, although this residue is indispensable for G protein activation. To investigate the importance of an ionic lock for overall receptor activity in a nonrhodopsin GPCR, we mutated R128(3.50) and E238(6.30) in the bradykinin (BK) B(2) receptor (B(2)R) and stably expressed the constructs in HEK293 cells. As expected, mutation of R3.50 resulted in lack of G protein activation. In addition, this mutation led to considerable constitutive receptor internalization. Mutation of E6.30 (mutants E6.30A and E6.30R) also caused strong constitutive internalization. Most intriguingly, however, although the two E6.30 mutants displayed no increased basal phosphatidylinositol hydrolysis, they gave a response to three different B(2)R antagonists that was almost comparable to that obtained with BK. In contrast, swapping of R3.50 and E6.30, thus allowing the formation of an inverse ionic bond, resulted in rescue of the wild type phenotype. These findings demonstrate for the first time, to our knowledge, that interruption of the ionic lock in a family A GPCR can have distinctly different effects on receptor internalization and G protein stimulation, shedding new light on its role in the activation process.

MeSH Terms
Amino Acids/metabolism Biotinylation Bradykinin/metabolism Bradykinin B2 Receptor Antagonists GTP-Binding Proteins/metabolism Gene Expression HEK293 Cells Humans Hydrolysis Inositol Phosphates/metabolism Ions/metabolism Phosphorylation Point Mutation Pyridones/pharmacology Quinolines/pharmacology Receptor, Bradykinin B2/agonists,drug effects Receptors, G-Protein-Coupled/drug effects,metabolism Temperature
Chemicals
1-(4-methyl-3-(2-methyl-4-(4-methyl-2H-pyrazol-3-yl)-quinolin-8-yloxymethyl)pyridin-2-ylmethyl)-3-trifluoromethyl-1H-pyridin-2-one Amino Acids Bradykinin B2 Receptor Antagonists Inositol Phosphates Ions Pyridones Quinolines Receptor, Bradykinin B2 Receptors, G-Protein-Coupled GTP-Binding Proteins Bradykinin
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Leschner Jasmin
Institut für Prophylaxe und Epidemiologie der Kreislaufkrankheiten, Ludwig-Maximilians-Universitaet, Pettenkoferstrasse 9, D-80336 Muenchen, Germany.
Wennerberg Goeran
Feierler Jens
Bermudez Marcel
Welte Benjamin
Kalatskaya Irina
Wolber Gerhard
Faussner Alexander
Article Info
Journal
The Journal of pharmacology and experimental therapeutics
Abbr.
J Pharmacol Exp Ther
ISSN
1521-0103
Published
2013-01-00
Epub
2012-00-18
Pages
85-95
Language
English
Region
United States
NLM ID
0376362
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com